Dymista Nasenspray Sospensione Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

dymista nasenspray sospensione

viatris pharma gmbh - azelastini hydrochloridum, fluticasoni propionas - sospensione - azelastini hydrochloridum 0.137 mg, fluticasoni propionas 0.05 mg, dinatrii edetas, glycerolum, cellulosum microcristallinum e carmellosum natricum, polysorbatum 80, benzalkonii chloridum 0,014 mg, alcol phenylethylicus, acqua purificata, alla sospensione per dosi. - saisonaler und perennialer allergischer schnupfen - synthetika

Flutiform 50/5 Druckgasinhalation, Suspension Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

flutiform 50/5 druckgasinhalation, suspension

mundipharma medical company, hamilton, bermuda, basel branch - fluticasoni propionas, formoteroli fumaras dihydricus - druckgasinhalation, suspension - fluticasoni propionas 50 µg pro dosi, formoteroli fumaras dihydricus 5 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. - asma bronchiale - synthetika

Flutiform 125/5 Druckgasinhalation, Suspension Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

flutiform 125/5 druckgasinhalation, suspension

mundipharma medical company, hamilton, bermuda, basel branch - fluticasoni propionas, formoteroli fumaras dihydricus - druckgasinhalation, suspension - fluticasoni propionas 125 µg pro dosi, formoteroli fumaras dihydricus 5 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. - asma bronchiale - synthetika

Flutiform 250/10 Druckgasinhalation, Suspension Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

flutiform 250/10 druckgasinhalation, suspension

mundipharma medical company, hamilton, bermuda, basel branch - fluticasoni propionas, formoteroli fumaras dihydricus - druckgasinhalation, suspension - fluticasoni propionas 250 µg pro dosi, formoteroli fumaras dihydricus 10 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. - asma bronchiale - synthetika

Seffalair Spiromax 55/14 mcg Multidosenpulverinhalator Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

seffalair spiromax 55/14 mcg multidosenpulverinhalator

teva pharma ag - fluticasoni propionas, salmeterolum - multidosenpulverinhalator - fluticasoni propionas 49 µg, salmeterolum 12.75 µg ut salmeteroli xinafoas, lactosum monohydricum ad pulverem pro dosi, doses pro vase 60. - asthma - synthetika

Seffalair Spiromax 113/14 mcg Multidosenpulverinhalator Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

seffalair spiromax 113/14 mcg multidosenpulverinhalator

teva pharma ag - fluticasoni propionas, salmeterolum - multidosenpulverinhalator - fluticasoni propionas 100 µg, salmeterolum 12.75 µg ut salmeteroli xinafoas, lactosum monohydricum ad pulverem pro dosi, doses pro vase 60. - asthma - synthetika

Seffalair Spiromax 232/14 mcg Multidosenpulverinhalator Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

seffalair spiromax 232/14 mcg multidosenpulverinhalator

teva pharma ag - fluticasoni propionas, salmeterolum - multidosenpulverinhalator - fluticasoni propionas 202 µg, salmeterolum 12.75 µg ut salmeteroli xinafoas, lactosum monohydricum ad pulverem pro dosi, doses pro vase 60. - asthma - synthetika

Clobetasol Leman 0.5mg/g shampoing Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

clobetasol leman 0.5mg/g shampoing

leman skl sa - clobetasoli propionas - shampoing - clobetasoli propionas 0.5 mg, acidum citricum monohydricum, natrii citras dihydricus, polyquaternium-10, natrii laurethsulfas, coco-betaine, ethanolum 96 per centum 100 mg, aqua purificata ad solutionem pro 1 g. - psoriasis et eczéma persistant du cuir chevelu - synthetika

Aerivio Spiromax Den Europæiske Union - italiensk - EMA (European Medicines Agency)

aerivio spiromax

teva b.v. - salmeterol xinafoate, fluticasone propionato - pulmonary disease, chronic obstructive; asthma - farmaci per le malattie respiratorie ostruttive, - aerivio spiromax è indicato per l'uso negli adulti dai 18 anni in su. asthmaaerivio spiromax è indicato per il trattamento regolare di pazienti con asma grave in cui l'uso di un prodotto di combinazione (corticosteroidi inalatori e long-acting β2 agonista) è appropriato:in pazienti non adeguatamente controllati con minore forza di corticosteroidi prodotto di combinazione orpatients già controllata con alte dosi di corticosteroidi inalatori e long-acting β2 agonista. malattia polmonare ostruttiva cronica (bpco)aerivio spiromax è indicato per il trattamento sintomatico di pazienti con bpco con fev1.

NAPRIUS Italien - italiensk - AIFA (Agenzia Italiana del Farmaco)

naprius

aesculapius farmaceutici srl - derivati dell'acido propionico - derivati dell'acido propionico